'%3e%3cpath%20d='M34.1406%205.85938C30.3906%202.10547%2025.3047%200%2020%200C14.6953%200%209.60938%202.10547%205.85938%205.85938C2.10938%209.61328%200%2014.6953%200%2020C0%2025.3047%202.10547%2030.3906%205.85938%2034.1406C9.61328%2037.8906%2014.6953%2040%2020%2040C25.3047%2040%2030.3906%2037.8945%2034.1406%2034.1406C37.8906%2030.3906%2040%2025.3047%2040%2020C40%2014.6953%2037.8945%209.60938%2034.1406%205.85938ZM37.0117%2023.543H31.1602V13.5391H27.6328V19.9414C28.1211%2020.6914%2028.3711%2021.582%2028.3711%2022.5625V22.625C28.3711%2023.668%2028.1172%2024.6055%2027.6328%2025.4297V26.6094H36.082C33.4883%2032.9375%2027.2891%2037.3789%2020.0039%2037.3789C10.3711%2037.3789%202.62109%2029.6289%202.62109%2020C2.62109%2010.3711%2010.3711%202.62109%2020%202.62109C29.6289%202.62109%2037.3789%2010.3711%2037.3789%2020C37.3789%2021.1484%2037.2617%2022.2656%2037.0508%2023.3477C37.0391%2023.4141%2037.0234%2023.4766%2037.0117%2023.543Z'%20fill='white'/%3e%3cpath%20d='M22.3086%2018.5352C20.4336%2018.125%2019.9531%2017.8398%2019.9766%2017.1836V17.1406C19.9766%2016.6992%2020.3477%2016.2148%2021.4023%2016.2148C22.582%2016.2148%2023.8867%2016.6797%2025.0781%2017.4766L26.8516%2015.0195C25.4453%2013.8906%2023.707%2013.3398%2021.5547%2013.3398C18.5195%2013.3398%2016.4375%2015%2016.4063%2017.4766V17.5352C16.3633%2020.2617%2018.5859%2020.9805%2021.293%2021.6016C23.0391%2021.9766%2023.5703%2022.3164%2023.5703%2022.9609L23.5469%2022.9766C23.5469%2023.3906%2023.2578%2023.7031%2022.7852%2023.8359C22.5742%2023.9062%2022.1289%2023.9727%2021.5156%2023.9727C20.7617%2023.9727%2019.7539%2023.8633%2018.6328%2023.4844C18.0898%2023.2891%2017.4727%2023.0039%2016.8047%2022.6133L20.1406%2026.625C20.2813%2026.6602%2021.0977%2026.8516%2021.7734%2026.8516C25.0039%2026.8516%2027.0859%2025.2461%2027.1094%2022.6328V22.5703C27.1602%2020.1133%2025.2148%2019.1719%2022.3086%2018.5352Z'%20fill='white'/%3e%3cpath%20d='M5.24219%2013.5664V26.6133H8.75391V23.7578L10.2969%2021.9531L14.2031%2026.6133H18.3867L12.3555%2019.5195L17.4023%2013.5664H13.4531L8.75391%2019.0586V13.5664H5.24219Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_97_2430'%3e%3crect%20width='40'%20height='40'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Lifestyle Features
Most Recent
Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall
Michael Erman and Julie Steenhuysen, Reuters | Updated Oct. 22 - 3:17 p.m. | Save Story
Moderna and Merck said on Thursday that their mRNA cancer vaccine when combined with Merck's widely used immunotherapy cut the risk of melanoma death or recurrence by 42% in a large trial, potentially paving the way for a new era of personalized treatment.
Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
Reuters | Updated Oct. 22 - 3:03 p.m. | Save Story
US biotech company Vor Bio said on Thursday its experimental kidney disease drug slowed the loss of kidney function and reduced the risk of disease progression in a late-stage study.
Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat
Kamal Choudhury, Reuters | Updated Oct. 22 - 2:18 p.m. | Save Story
Moderna's shares sank over 25% on Thursday as late-stage trial data for its personalized melanoma vaccine, developed with Merck, triggered what analysts called a "sell-the-news" reaction after a months-long stock surge.
The connection between having in-person friends and problematic social media use
Kara Alaimo, CNN | Posted Oct. 22 - 2:13 p.m. | Save Story
Do you spend too much time on social media? Is it interfering with other parts of your life? New research suggests what could be driving your behavior.
Taco Bell sticks with Pepsi as sister chain switches to Coke
Jordan Valinsky, CNN | Updated Oct. 22 - 2:03 p.m. | Save Story
KFC dumped PepsiCo last week, but its sister chain Taco Bell announced Thursday it's keeping the Mountain Dew Baja Blast maker on for another decade.
France reports first human case of livestock virus Shamonda after patient dies
Sybille de La Hamaide and Gus Trompiz, Reuters | Updated Oct. 22 - 12:58 p.m. | Save Story
France reported the first human case of the Shamonda virus usually found in livestock on Thursday in a hospital patient who died, though authorities said there was no risk to the general population.
Laboratory operator Quest reports cyber breach affecting patient records
Reuters | Updated Oct. 22 - 9:34 a.m. | Save Story
Quest Diagnostics on Thursday said it learned of unauthorized access to its Quanum LSM system, which some clients use to place test orders, receive and look up results.
Airbnb rule change frees guests from chores involving 'significant effort'
Charlotte Reck, CNN | Updated Oct. 22 - 9:11 a.m. | Save Story
Airbnb has revised its rules to reduce the tasks a host can expect a guest to perform at the end of their stay — and washing dishes has been wiped from the to-do list.
AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination
Christy Santhosh, Reuters | Updated Oct. 22 - 9:06 a.m. | Save Story
AbbVie said on Thursday its experimental drug significantly reduced inflammatory lumps and abscesses in patients with a chronic skin disease, meeting the main goal of a late-stage study.
Roche beats revenue estimates, shares slip as copycats eat into Xolair sales
Patrick Wingrove and Marleen Kaesebier, Reuters | Updated Oct. 22 - 8:07 a.m. | Save Story
ZURICH/ LONDON, Oct 22 - Swiss drugmaker Roche beat third-quarter sales expectations on Thursday, supported by steady demand for key medicines such as Ocrevus to buy time as it looks abroad to restock a pipeline facing looming patent expiries.
Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Richa Naidu, Dominique Patton and Alexander Marrow, Reuters | Updated Oct. 22 - 4:56 a.m. | Save Story
Swiss skincare firm Galderma, Brazilian cosmetics group Natura and beauty giant L'Oreal are testing treatments for consumers worried about facial sagging and volume loss, looking to capitalise on a growing market tied to the boom in obesity drugs.
Galderma lifts outlook for second quarter in a row after sales jump
Reuters | Updated Oct. 22 - 4:18 a.m. | Save Story
Swiss skincare company Galderma raised its full-year sales guidance on Thursday for the second time in two quarters after strong demand for its therapeutic dermatology products drove robust growth in the first nine months of the year.
New World screwworm cases confirmed in wildlife in Texas, beef cow in New Mexico
Kanishka Singh, Reuters | Updated Oct. 21 - 7:16 p.m. | Save Story
The US Department of Agriculture said on Wednesday it confirmed the first detection of flesh-eating parasite New World screwworm in US wildlife in an elk in Pecos County, Texas, while New Mexico authorities separately said they confirmed a case in a beef cow.
New Zealand's Fisher & Paykel Healthcare hit by cyber breach
Reuters | Updated Oct. 21 - 7:16 p.m. | Save Story
Medical device maker Fisher & Paykel Healthcare on Thursday said it was made aware of unauthorized and unlawful access to a subset of company files and two employee email accounts.
EQT to buy molecular testing firm Qiagen for $10.8 billion
Reuters | Updated Oct. 21 - 4:48 p.m. | Save Story
Sweden's EQT will buy molecular testing company Qiagen for about €9.6 billion ($10.78 billion), the companies said on Wednesday, ending years of takeover speculation surrounding the Dutch firm.
Utah Apple Crunch connects kindergarteners with local farmers
VideoMadi Vollmer, KSL | Posted Oct. 21 - 3:04 p.m. | Save Story
About 150 kindergarteners from Canyons School District met local apple farmers at the state Capitol to learn where their food comes from and the importance of healthy eating.
Elevance lifts 2026 profit forecast on disciplined cost management
Sneha S K and Kamal Choudhury, Reuters | Updated Oct. 21 - 10:05 a.m. | Save Story
Elevance Health on Wednesday raised its annual profit forecast after posting better-than-expected quarterly results, helped by lower medical costs.
Cencora to buy American Oncology Network in $2.4 billion deal
Sriparna Roy, Reuters | Updated Oct. 21 - 10:02 a.m. | Save Story
Drug distributor Cencora said on Wednesday it would acquire American Oncology Network in a deal valuing the cancer care provider at up to $2.4 billion, deepening its reach in community oncology across the United States.
